PharmTech AI Pulse Check episode 2 covers AI data governance, API-gated journals, watermarking limits, and why attribution beats detection in GxP.
News|Articles|February 11, 2019
CO2 Incubators Available in the EU
Author(s)Pharmaceutical Technology Editors
Caron’s Wally CO2 incubators for laboratories are now available for purchase in the European Union.
Caron, a supplier of temperature and environmental control equipment, announced on Feb. 11, 2019 that its Wally CO2 incubators are now CE-certified and available for sale in the European Union.
According to the company, the incubator’s wall-hugging format makes the most of tight lab environments, opening up aisles and hallways to improve workflows. The slim profile also cuts out wasted shelf space, reportedly giving users twice the usable culture area of existing incubators.
Features include patented GelJacket thermal protection with temperature maintenance after power loss of a water jacket, hands-free door opening, ISO-5 air filtration, available two-hour dry H2O2 chamber sterilization, and touchscreen display with intuitive breadcrumb navigation.
Source:
Related to this article
The FDA opened an expedited IND pilot, tightened scrutiny of foreign trial data, and finalized a rule recognizing non-animal testing methods. In Europe, the EMA advanced pharmaceutical legislation reform, restricted 2 legacy products, and opened an injectable-iron safety review.
Novartis licenses Abogen's mRNA-encoded T-cell engager for autoimmune disease, raising scale-up questions for mRNA-lipid nanoparticle manufacturing.
Pharma manufacturing spent 90 years learning that producing correct outputs isn't the same as catching your own errors. AI has only learned the first.
Ron Scarboro, Azurity Pharmaceuticals, explains why real-world usability belongs at product definition and how post-launch feedback should guide drug formulation.
Ronald Piervincenzi, USP, explains why drug supply resilience needs a system approach, from procurement benchmarks to regulatory capacity building.
Gene manufacturing platforms, patient-centric formulations, contract services, packaging innovations, and sterile filling lines are in the spotlight at CPHI Milan 2026.
Ronald Piervincenzi, USP, explains why drug supply resilience needs a system approach, from procurement benchmarks to regulatory capacity building.